NASDAQ:IRWD Ironwood Pharmaceuticals (IRWD) News Today $11.06 +0.03 (+0.27%) (As of 01:34 PM ET) Add Compare Share Share Today's Range$10.76▼$11.1150-Day Range$10.10▼$11.2352-Week Range$9.73▼$12.66Volume486,025 shsAverage Volume2.26 million shsMarket Capitalization$1.71 billionP/E Ratio10.95Dividend YieldN/APrice Target$15.67 HeadlinesProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Get Ironwood Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IRWD and its competitors with MarketBeat's FREE daily newsletter. Email Address IRWD Media Mentions By Week IRWD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IRWD News Sentiment▼-0.070.56▲Average Medical News Sentiment IRWD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IRWD Articles This Week▼83▲IRWD Articles Average Week All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineIronwood Pharmaceuticals (NASDAQ:IRWD) Upgraded at StockNews.comamericanbankingnews.com - June 3 at 5:15 AMIronwood Pharmaceuticals (IRWD) Presents At Life Sciences Conference -Slideshowseekingalpha.com - June 2 at 9:40 AMIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) CEO Thomas A. Mccourt Sells 26,632 Shares of Stockamericanbankingnews.com - June 2 at 8:46 AMIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) to Post Q3 2023 Earnings of $0.27 Per Share, Zacks Research Forecastsamericanbankingnews.com - May 31 at 1:48 AMIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Acquired by Dimensional Fund Advisors LPmarketbeat.com - May 30 at 5:18 AMRussell Investments Group Ltd. Grows Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)marketbeat.com - May 29 at 4:30 AMZacks Research Brokers Lower Earnings Estimates for Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)marketbeat.com - May 29 at 1:36 AMIronwood Pharmaceuticals (NASDAQ:IRWD) Downgraded by StockNews.com to "Buy"americanbankingnews.com - May 26 at 6:11 AMIronwood Pharmaceuticals (NASDAQ:IRWD) PT Raised to $19.00 at Piper Sandleramericanbankingnews.com - May 25 at 3:10 AMIronwood Pharmaceuticals (NASDAQ:IRWD) Downgraded to Buy at StockNews.commarketbeat.com - May 25 at 1:22 AMIronwood Pharmaceuticals to Buy VectivBio for $1 Billion, Enhancing Gastrointestinal Portfoliomsn.com - May 23 at 5:04 PMPiper Sandler Maintains Ironwood Pharmaceuticals Inc - (IRWD) Overweight Recommendationmsn.com - May 23 at 5:04 PMUBS Group AG Grows Stock Position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)marketbeat.com - May 23 at 5:00 AMIronwood Pharma to acquire Swiss-based VectivBio in $1 bln dealreuters.com - May 22 at 8:28 PMIronwood falls 15% on deal to buy VectivBio for $17/share cashseekingalpha.com - May 22 at 8:28 PMWhy Ironwood Pharmaceuticals Stock Bumped Higher Todayfinance.yahoo.com - May 22 at 8:28 PMIronwood Scoops Up Gastrointestinal Diseases Player For $1Bmarkets.businessinsider.com - May 22 at 3:27 PMIronwood Snaps Up VectivBio in GI Pushmsn.com - May 22 at 10:27 AMWhy VectivBio Shares Are Surging Mondaymarkets.businessinsider.com - May 22 at 10:27 AMIronwood Enters into Definitive Agreement to Acquire VectivBio, a Clinical-Stage Biotech Company Pioneering Novel Treatments for Severe Rare Gastrointestinal Diseasesfinance.yahoo.com - May 22 at 10:27 AMIronwood Pharmaceuticals to Buy VectivBio in $1 Billion Deal. The Sector Is Hot for M&A.finance.yahoo.com - May 22 at 10:27 AMIronwood Pharmaceuticals (NASDAQ:IRWD) Upgraded by StockNews.com to "Strong-Buy"americanbankingnews.com - May 21 at 1:54 AMJupiter Asset Management Ltd. Has $3.02 Million Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)marketbeat.com - May 19 at 9:34 AM9,950 Shares in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Acquired by SG Americas Securities LLCmarketbeat.com - May 16 at 4:15 AMState Board of Administration of Florida Retirement System Sells 62,439 Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)marketbeat.com - May 14 at 4:48 AMIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) CEO Sells $224,591.76 in Stockamericanbankingnews.com - May 13 at 5:54 AMOak Associates Ltd. OH Acquires 174,849 Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)marketbeat.com - May 12 at 11:24 AMIronwood Pharmaceuticals to Participate in The JMP Securities Life Sciences Conferencefinance.yahoo.com - May 9 at 8:25 PMIronwood Presents New Data on Potential of Linaclotide for Functional Constipation in Children and Adolescents Ages 6-17 Years-Old at Digestive Disease Week® 2023finance.yahoo.com - May 8 at 11:14 AMFY2023 Earnings Estimate for Ironwood Pharmaceuticals, Inc. Issued By Capital One Financial (NASDAQ:IRWD)americanbankingnews.com - May 7 at 2:32 AMIronwood Pharmaceuticals, Inc. (IRWD) Q1 2023 Earnings Call Transcriptseekingalpha.com - May 6 at 6:23 PMIronwood Pharmaceuticals (NASDAQ:IRWD) Releases Earnings Results, Beats Estimates By $0.01 EPSmarketbeat.com - May 5 at 2:42 PMRecap: Ironwood Pharmaceuticals Q1 Earningsmsn.com - May 4 at 12:47 PMIronwood Pharmaceuticals (IRWD) Surpasses Q1 Earnings and Revenue Estimatesfinance.yahoo.com - May 4 at 12:47 PMIronwood Pharmaceuticals Reports First Quarter 2023 Results; Maintains Full Year 2023 Financial Guidancefinance.yahoo.com - May 4 at 7:47 AMQ1 2023 Earnings Estimate for Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Issued By Capital One Financialamericanbankingnews.com - May 3 at 1:20 AMIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Expected to Post Q1 2023 Earnings of $0.23 Per Sharemarketbeat.com - May 1 at 1:17 AMIronwood Pharmaceuticals (IRWD) Set to Announce Earnings on Thursdayamericanbankingnews.com - April 27 at 5:15 AMIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Stock Holdings Lessened by Comerica Bankmarketbeat.com - April 25 at 4:23 AMIronwood to Present New Data at Digestive Disease Week® 2023 Demonstrating Potential of Linaclotide for Functional Constipation in Children and Adolescents Ages 6-17 Years-Oldfinance.yahoo.com - April 24 at 8:13 AMState of New Jersey Common Pension Fund D Has $2.49 Million Position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)marketbeat.com - April 24 at 5:37 AMShort Interest in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Rises By 8.0%americanbankingnews.com - April 22 at 2:56 AMNew York State Common Retirement Fund Cuts Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)marketbeat.com - April 21 at 4:55 AMIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Sees Large Increase in Short Interestmarketbeat.com - April 21 at 1:36 AMIronwood Pharmaceuticals to Host First Quarter 2023 Investor Update Callfinance.yahoo.com - April 20 at 6:44 PMAllspring Global Investments Holdings LLC Reduces Position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)marketbeat.com - April 14 at 4:26 AMEquities Analysts Offer Predictions for Ironwood Pharmaceuticals, Inc.'s Q2 2024 Earnings (NASDAQ:IRWD)marketbeat.com - April 7 at 8:38 AMIronwood Pharmaceuticals (NASDAQ:IRWD) Sees Strong Trading Volumeamericanbankingnews.com - April 1 at 9:02 AMIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) CEO Thomas A. Mccourt Sells 46,129 Sharesamericanbankingnews.com - March 30 at 7:01 AMIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Sold by Assenagon Asset Management S.A.marketbeat.com - March 30 at 4:27 AM Get Ironwood Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for IRWD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Geron News Dynavax Technologies News Ligand Pharmaceuticals News MannKind News OPKO Health News Innoviva News Lexicon Pharmaceuticals News Intercept Pharmaceuticals News Emergent BioSolutions News ImmunoGen News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:IRWD) was last updated on 6/5/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ironwood Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.